全文获取类型
收费全文 | 149篇 |
免费 | 6篇 |
国内免费 | 11篇 |
专业分类
儿科学 | 1篇 |
基础医学 | 28篇 |
临床医学 | 4篇 |
内科学 | 95篇 |
神经病学 | 2篇 |
特种医学 | 3篇 |
外科学 | 22篇 |
预防医学 | 3篇 |
药学 | 6篇 |
肿瘤学 | 2篇 |
出版年
2023年 | 1篇 |
2021年 | 1篇 |
2020年 | 1篇 |
2019年 | 3篇 |
2018年 | 2篇 |
2017年 | 2篇 |
2016年 | 4篇 |
2015年 | 5篇 |
2014年 | 3篇 |
2013年 | 6篇 |
2012年 | 13篇 |
2011年 | 17篇 |
2010年 | 6篇 |
2009年 | 10篇 |
2008年 | 14篇 |
2007年 | 13篇 |
2006年 | 16篇 |
2005年 | 12篇 |
2004年 | 7篇 |
2003年 | 6篇 |
2002年 | 8篇 |
2001年 | 1篇 |
1999年 | 1篇 |
1998年 | 3篇 |
1997年 | 2篇 |
1996年 | 2篇 |
1995年 | 1篇 |
1994年 | 2篇 |
1993年 | 1篇 |
1991年 | 3篇 |
排序方式: 共有166条查询结果,搜索用时 31 毫秒
81.
Taylor LS Rubens DJ Porter BC Wu Z Baggs RB di Sant'Agnese PA Nadasdy G Pasternack D Messing EM Nigwekar P Parker KJ 《Radiology》2005,237(3):981-985
PURPOSE: To prospectively evaluate the accuracy of three-dimensional (3D) sonoelastographic imaging, relative to that of gray-scale ultrasonography (US), in the in vitro detection of prostate cancer. MATERIALS AND METHODS: The study was approved by the institutional review board and was HIPAA compliant. Informed consent was obtained from all patients. Nineteen prostatectomy specimens from patients aged 46-70 years with biopsy-proved prostate cancer were scanned in three dimensions by using conventional B-mode US and sonoelastography with vibrations of more than 100 Hz. Step-sectioned whole-mount histologic specimens were used to create a 3D volume of the prostate and the tumors within it. B-mode US scans and regions of low vibration on the sonoelastographic images (hard regions) were formatted in three dimensions. The lesions in the 19 cases were classified into two groups, as follows: G1 lesions were pathologically confirmed tumors with a volume of at least 1.0 cm3, and G2 lesions were pathologically confirmed tumors smaller than 1.0 cm3. G1 lesions were evaluated with B-mode US and sonoelastography and classified as true-positive, false-positive, true-negative, or false-negative; G2 lesions were evaluated only with sonoelastography. Findings at histologic examination were used as the reference standard. True-positive findings necessitated 3D lesion correlation between pathologic and imaging data. Conventional definitions of accuracy and sensitivity were used for statistical analysis. RESULTS: For G1 lesions (seven lesions with a volume of at least 1.0 cm3), sonoelastography had an accuracy of 55% and a sensitivity of 71% and B-mode US had an accuracy of 17% and a sensitivity of 29%. The mean tumor volume was 3.1 cm3 +/- 2.1 (standard deviation). For G2 lesions (22 lesions with a volume of less than 1.0 cm3), the mean tumor volume was 0.32 cm3 +/- 0.21. Sonoelastography had an accuracy of 34% and a sensitivity of 41%; there were six false-positive findings. CONCLUSION: Sonoelastography performed considerably better than did gray-scale US in the depiction of prostate cancer for tumors with volumes of more than 1 cm3. 相似文献
82.
Szabo G Hoek JB Darley-Usmar V Hajnoczky G Knudsen T Mochly-Rosen D Zakhari S 《Alcoholism, clinical and experimental research》2005,29(9):1749-1752
This article summarizes the proceedings of the RSA 2004 Combined Basic Research Satellite Meeting convened at the Westin Bayshore Resort and Marina, Vancouver, CA. One of the sessions "Alcohol and mitochondrial metabolism: At the crossroads of life and death" featured five speakers and was chaired by Drs. Jan Hoek and Sam Zakhari. The presentations were 1) Introduction: Alcohol and cellular energy metabolism by Jan Hoek, 2) Ethanol-dependent dysfunction of mitochondrial energy metabolism: the role of NO by Victor Darley-Usmar, 3) Ethanol and apoptosis in the heart by Gyorgy Hajnoczky, 4) Alcohol and mitochondrial biogenesis in development by Thomas Knudsen, and 5) Alcohol, mitochondrial function and cardiac preconditioning by Daria Mochly-Rosen. 相似文献
83.
84.
Role of elevated monocyte transforming growth factorβ (TGFβ) production in posttrauma immunosuppression 总被引:7,自引:0,他引:7
Carol L. Miller-Graziano Gyongyi Szabo Katherine Griffey Bela Mehta Karen Kodys Donna Catalano 《Journal of clinical immunology》1991,11(2):95-102
We previously reported that increased production of prostaglandin E2 by monocytes is a pivotal mechanism in posttrauma immunopathology. Here we characterize monocyte levels of transforming growth factor and examine the effects of elevated transforming growth factor on prostaglandin E2 release by patients' monocytes. Trauma patients' and normals' monocyte supernates (± stimulation with muramyl dipeptide) were acid treated and assayed for transforming growth factor using the mink lung-cell bioassay. Alternatively, human transforming growth factor was added to patients' and normals' monocytes and prostaglandin E2 production assayed. Significantly elevated transforming growth factor levels (median=181.7 pmol/106 monocytes) were detected in immunosuppressed patients' monocytes but not immuno-competent trauma patients' (median=32.0 pM) or normals' (median=20.4 pM) monocytes. Adding transforming growth factor to monocytes resulted in a significant elevation of prostaglandin E2 levels. Elevated monocyte transforming growth factor levels in trauma patients could be both suppressing T-lymphocyte functions and maintaining elevated monocyte prostaglandin E2 synthesis. 相似文献
85.
86.
Infection with hepatitis C virus (HCV) is a public health problem; it establishes a chronic course in ~85% of infected patients
and increases their risk for developing liver cirrhosis, hepatocellular carcinoma, and significant extrahepatic manifestations.
The mechanisms of HCV persistence remain elusive and are largely related to inefficient clearance of the virus by the host
immune system. Dendritic cells (DCs) are the most efficient inducers of immune responses; they are capable of triggering productive
immunity and maintaining the state of tolerance to self- and non-self antigens. During the past decade, multiple research
groups have focused on DCs, in hopes of unraveling an HCV-specific DC signature or DC-dependent mechanisms of antiviral immunity
which would lead to a successful HCV elimination strategy. This review incorporates the latest update in the current status
of knowledge on the role of DCs in anti-HCV immunity as it relates to several challenging questions: (a) the phenotype and
function of diverse DC subsets in HCV-infected patients; (b) the characteristics of non-human HCV infection models from the
DCs’ point of view; (c) how can in vitro systems, ranging from HCV protein- or peptide-exposed DC to HCV protein-expressing
DCs, and in vivo systems, ranging from HCV protein-expressing transgenic mice to HCV-infected non-human primates, be employed
to dissect the role of DCs in triggering/maintaining a robust antiviral response; and (d) the prospect of DC-based strategy
for managing and finding a cure for HCV infection. 相似文献
87.
Despite progress in therapeutic approaches for the elimination of hepatitis C, chronic hepatitis C virus infection remains
an important cause of liver disease. Therapeutic intervention with the currently available interferon-based treatment regimens
is quite successful, but treatment is difficult to tolerate and is contraindicated in many patients. A better understanding
of the HCV biology, immunopathology, and liver disease will help to design better therapeutic strategies. The American Association
for the Study of Liver Diseases sponsored a single-topic conference on hepatitis C virus infection on March 4 and 5, 2005,
to enhance our current knowledge in the areas of basic and clinical research related to antiviral and immunomodulatory therapies
in hepatitis C disease. The faculty consisted of 23 invited experts in the field of viral hepatitis. The program was divided
into four sections including: (a) replicative mechanisms and models; (b) viral-host interactions; and (c) antiviral drug development
and new strategies; and (d) back to the bedside—current issues. This report summarizes each of the presentations sections.
This report is from the 2005 Single Topic Conference on Hepatitis C. The conference was sponsored by the American Association
for the Study of Liver Diseases with the support of the AASLD/Roche Pharmaceuticals Hepatitis Single Topic Conference Endowment. 相似文献
88.
89.
Zhang X Jin M Wu H Nadasdy T Nadasdy G Harris N Green-Church K Nagaraja H Birmingham DJ Yu CY Hebert LA Rovin BH 《Kidney international》2008,74(6):799-807
Lupus nephritis is a frequent and serious complication of systemic lupus erythematosus (SLE), the treatment of which often requires the use of immunosuppressives that can have severe side effects. Here we determined the low-molecular weight proteome of serial lupus urine samples to uncover novel and predictive biomarkers of SLE renal flare. Urine from 25 flare cycles of 19 patients with WHO Class III, IV, and V SLE nephritis were obtained at baseline, pre-flare, flare and post-flare. Each sample was first fractionated to remove proteins larger than 30 kDa, then applied onto weak cation exchanger protein chips for analysis by SELDI-TOF mass spectrometry. We found 176 protein ions of which 27 were differentially expressed between specific flare intervals. On-chip peptide sequencing by integrated tandem mass spectrometry positively identified the 20 and 25 amino-acid isoforms of hepcidin, as well as fragments of alpha1-antitrypsin and albumin among the selected differentially expressed protein ions. Hepcidin 20 increased 4 months before renal flare and returned to baseline at renal flare, whereas hepcidin 25 decreased at renal flare and returned to baseline 4 months after the flare. These studies provide a beginning proteomic analysis aimed at predicting impending renal relapse, relapse severity, and the potential for recovery after SLE nephritis flare. 相似文献
90.